The prosecution rested years ago. The androgen receptor (AR) was found guilty of driving prostate cancer - case closed, gavel down, everybody go home. Doctors threw the book at it with drugs like enzalutamide that clamp down on AR's ligand-binding domain like handcuffs on a suspect. But here's...
Your CD8 T cells are supposed to be the closer, the pass rush, the late-game assassin - pick your sport. They find infected or malignant cells, hit them hard, and keep the scoreboard moving in your favor. But when a fight drags on, those same cells can slide into T cell exhaustion, a state where...
A gardener who rips out every plant in the bed - roses and crabgrass alike - then concludes "nothing here was worth growing" hasn't really proven anything about roses. That, in a nutshell, is what three prominent Alzheimer's researchers just argued happened to the latest big-ticket review of...
The moment the first scan showed that a heavily pretreated ROS1-positive lung cancer had actually shrunk - and not just in the chest, but in the place doctors dread most, the brain - the researchers likely did what scientists do when they're internally screaming: they opened a spreadsheet and tried...
The smell of palmitic acid in a centrifuge tube is unremarkable - a faint, waxy nothing. It's the kind of molecule you'd walk right past in a lab without a second thought. But researchers at Nanjing University just caught this boring little fatty acid red-handed, running one of the most devious...
The problem with breast cancer's growth engine is that it does not just hit the gas - it studies the brake system, hires a locksmith, and comes back with a grudge. That is the world cyclin-dependent kinase, or CDK, inhibitors enter: a fight over whether cancer cells get to keep dividing like they...
Introducing MARCO: the immune receptor that helps tumors hide from your body's defenses - and the antibody that might shut it down.
Every great spy thriller has a mole - someone on the inside, passing secrets to the enemy, sabotaging missions from within. Your CAR T-cells, those genetically engineered assassins we send to hunt cancer, have been dealing with exactly this kind of double-agent problem. And a team of researchers...
Too much testosterone might kill you during COVID-19 - and too little testosterone might kill you just as fast.
Over 1,000 spatial transcriptomics samples were enough to inspire a 2025 practical guide, which is science-speak for: this field has officially outgrown the "cool demo" phase and entered the "please help, our data all speak different dialects" phase [6].
The review by Ofori-Amanfo, Dustin, and Lim looks at a fast-growing field where air pollution meets data science and lung health [1]. The basic idea is simple enough to explain over fries: pollution does not just irritate the lungs in a vague, hand-wavy way. It appears to nudge multiple biological...
Archaeologists spend years brushing dirt off one stubborn corner of the earth only to realize the "empty patch" was actually a city with plumbing, politics, and probably at least one guy skimming taxes. Brain metastases from breast cancer just got a similar plot twist. What looked like a barren...
DMG is a rare, aggressive brain tumor that usually strikes children and young adults. It tends to grow in the brainstem, thalamus, or spinal cord, which is a rotten place to have a tumor because those areas run the basics like movement, swallowing, and breathing. Surgery is often not realistic....
If E-cadherin is part of the Velcro that keeps neighboring epithelial cells attached, claudin-4 is part of the seal that helps keep the gut lining from turning into a leaky apartment building. The new paper shows that BFT does not just wander up and hack randomly at the wall like a raccoon with...
Pancreatic ductal adenocarcinoma is brutal partly because it gets very good at ignoring chemotherapy. One reason is something called epithelial-to-mesenchymal transition, or EMT. In normal biology, EMT helps cells become more mobile during development and wound repair. In cancer, it is more like a...
Breast cancer that spreads to the brain is one of oncology's meaner plot twists. It is dangerous, hard to treat, and loaded with biological nonsense that keeps grad students humble and antibodies unemployed. For years, brain metastases often got labeled "immune cold," which is science-speak for...
In Brisbane, where the river loops around the city like it has all the time in the world, a group of scientists went hunting for a very specific kind of cellular nonsense: why a prostate cancer protein called EphB4 hangs around longer than it probably should. And honestly, that is exactly the kind...
Mycosis fungoides, or MF, is the most common type of cutaneous T-cell lymphoma - a cancer of immune cells that prefers to loiter in the skin like it pays rent there [6,7]. It often behaves slowly, which sounds comforting until you remember that “slow” in cancer biology can also mean “sneaky enough...
Somewhere inside nasopharyngeal carcinoma, the enemy appears to be running a counterintelligence operation - the kind where your supposed bodyguards start acting like confused mall cops, one squad still ready to tackle intruders while another seems weirdly content to wave the bad guys through....
Triple-negative breast cancer, or TNBC, is the breast cancer subtype that lacks estrogen receptor, progesterone receptor, and HER2. Translation: a lot of the usual therapeutic handles are missing, which is rude and deeply inconvenient [5].